Trademark: 97521894
Word
NAXVYTA
Status
Pending
Status Code
688
Status Date
Tuesday, September 12, 2023
Serial Number
97521894
Mark Type
4000
Filing Date
Wednesday, July 27, 2022
Published for Opposition
Tuesday, July 18, 2023

Trademark Owner History
AMPHASTAR PHARMACEUTICALS, INC. - Owner At Publication

Classifications
5 Pharmaceutical preparations, namely, opioid antagonists and narcotic antagonists; pharmaceutical and drug preparations for use in treatment of opiate, opioid or narcotic overdose; Intranasal drug delivery devices, injector devices for nasal delivery, or devices for nasal delivery, all pre-filled with pharmaceuticals, namely, opioid antagonists and narcotic antagonists and pharmaceutical and drug preparations for use in treatment of opiate, opioid or narcotic overdose; nasal spray preparations
44 Medical and health information services; Providing a website for patients, medical professionals, and pharmacists featuring medical information in the fields of health, medicine, opioids and narcotics, opioid antagonists and narcotic antagonists, drug overdoses, and emergency medical tips; providing a website featuring pharmaceutical drug information relating to diagnostic, prophylactic and therapeutic properties of naloxone, opioid antagonists and narcotic antagonists

Trademark Events
Sep 12, 2023
Noa E-Mailed - Sou Required From Applicant
Jul 18, 2023
Official Gazette Publication Confirmation E-Mailed
Jul 18, 2023
Published For Opposition
Jun 28, 2023
Notification Of Notice Of Publication E-Mailed
Jun 9, 2023
Approved For Pub - Principal Register
Jun 9, 2023
Examiner's Amendment Entered
Jun 9, 2023
Notification Of Examiners Amendment E-Mailed
Jun 9, 2023
Examiners Amendment E-Mailed
Jun 9, 2023
Examiners Amendment -Written
Jun 5, 2023
Previous Allowance Count Withdrawn
May 30, 2023
Withdrawn From Pub - Og Review Query
May 15, 2023
Approved For Pub - Principal Register
May 15, 2023
Assigned To Examiner
Aug 3, 2022
New Application Office Supplied Data Entered
Jul 30, 2022
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24